Benyao Lin

1.7k total citations
56 papers, 1.2k citations indexed

About

Benyao Lin is a scholar working on Cancer Research, Oncology and Genetics. According to data from OpenAlex, Benyao Lin has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cancer Research, 32 papers in Oncology and 27 papers in Genetics. Recurrent topics in Benyao Lin's work include Breast Cancer Treatment Studies (26 papers), BRCA gene mutations in cancer (24 papers) and DNA Repair Mechanisms (13 papers). Benyao Lin is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), BRCA gene mutations in cancer (24 papers) and DNA Repair Mechanisms (13 papers). Benyao Lin collaborates with scholars based in China, Ethiopia and Switzerland. Benyao Lin's co-authors include Yuntao Xie, Zhaoqing Fan, Tie Fan, Jinfeng Li, Tao Ouyang, Tianfeng Wang, Tianfeng Wang, Ye Xu, Tao Ouyang and Lu Yao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Benyao Lin

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benyao Lin China 18 606 583 565 501 187 56 1.2k
Tie Fan China 18 546 0.9× 572 1.0× 455 0.8× 472 0.9× 181 1.0× 53 1.1k
Chiyomi Egawa Japan 20 740 1.2× 471 0.8× 628 1.1× 302 0.6× 140 0.7× 69 1.4k
Zhaoqing Fan China 23 787 1.3× 850 1.5× 821 1.5× 755 1.5× 309 1.7× 109 1.8k
Tatyana A. Grushko United States 16 666 1.1× 333 0.6× 658 1.2× 475 0.9× 77 0.4× 22 1.4k
Kirsi Syrjäkoski Finland 20 803 1.3× 933 1.6× 304 0.5× 409 0.8× 333 1.8× 26 1.5k
Christine S. L. Lee Australia 18 636 1.0× 506 0.9× 709 1.3× 236 0.5× 67 0.4× 19 1.2k
Anne‐Lise Børresen‐Dale Norway 15 822 1.4× 210 0.4× 446 0.8× 527 1.1× 84 0.4× 20 1.2k
Farahnaz Forozan United States 7 662 1.1× 320 0.5× 340 0.6× 275 0.5× 128 0.7× 8 1.0k
Lauren Brusco United States 11 320 0.5× 221 0.4× 333 0.6× 468 0.9× 139 0.7× 17 804
Hans Kristian Moen Vollan Norway 18 705 1.2× 165 0.3× 466 0.8× 573 1.1× 97 0.5× 25 1.3k

Countries citing papers authored by Benyao Lin

Since Specialization
Citations

This map shows the geographic impact of Benyao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benyao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benyao Lin more than expected).

Fields of papers citing papers by Benyao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benyao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benyao Lin. The network helps show where Benyao Lin may publish in the future.

Co-authorship network of co-authors of Benyao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Benyao Lin. A scholar is included among the top collaborators of Benyao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benyao Lin. Benyao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Liming, Tao Ouyang, Jinfeng Li, et al.. (2021). Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers. Cancer Research. 81(10). 2600–2611. 48 indexed citations
2.
Xu, Ye, Lu Yao, Tao Ouyang, et al.. (2019). Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer. International Journal of Cancer. 146(2). 487–495. 17 indexed citations
3.
Chen, Xinyi, Tao Ouyang, Jinfeng Li, et al.. (2019). Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer. Journal of Cancer Research and Clinical Oncology. 145(5). 1235–1242. 14 indexed citations
4.
Ouyang, Tao, Jinfeng Li, Tianfeng Wang, et al.. (2019). Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients. Breast Cancer Research and Treatment. 174(3). 639–647. 17 indexed citations
5.
Sun, Jie, Hua Meng, Lu Yao, et al.. (2017). Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients. Clinical Cancer Research. 23(20). 6113–6119. 145 indexed citations
6.
Xu, Ye, Tao Ouyang, Jinfeng Li, et al.. (2017). HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer. Oncology Letters. 13(5). 3793–3798. 2 indexed citations
7.
Zhang, Juan, Tao Ouyang, Jinfeng Li, et al.. (2016). Incidence of BRCA1 somatic mutations and response to neoadjuvant chemotherapy in Chinese women with triple-negative breast cancer. Gene. 584(1). 26–30. 11 indexed citations
8.
Yuan, Hua, Yiqiang Liu, Tao Ouyang, et al.. (2015). Association of PIK3CA Mutation Status before and after Neoadjuvant Chemotherapy with Response to Chemotherapy in Women with Breast Cancer. Clinical Cancer Research. 21(19). 4365–4372. 25 indexed citations
9.
Sun, Jie, Yuxia Wang, Yisui Xia, et al.. (2015). Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer. PLoS Genetics. 11(5). e1005228–e1005228. 73 indexed citations
10.
Xu, Ye, Wei Yan, Tao Ouyang, et al.. (2013). Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer. Frontiers of Medicine. 7(1). 138–142. 8 indexed citations
11.
Fan, Zhaoqing, Jinfeng Li, Tianfeng Wang, et al.. (2013). Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy. The Breast. 22(6). 1161–1165. 10 indexed citations
12.
Liu, Yin, Ji Liao, Ye Xu, et al.. (2011). A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women. Human Mutation. 32(9). 1000–1003. 22 indexed citations
13.
Li, Zhaosheng, Lu Yao, Yiqiang Liu, et al.. (2011). Breast cancer subtypes and survival in Chinese women with operable primary breast cancer. Chinese Journal of Cancer Research. 23(2). 134–139. 13 indexed citations
14.
Ouyang, Tao, Tianfeng Wang, Yuntao Xie, et al.. (2010). [The clinical research of local recurrence after breast-conserving therapy for breast cancer].. PubMed. 48(24). 1851–4. 1 indexed citations
15.
Shi, Liang, Bin Dong, Zhongwu Li, et al.. (2009). Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer. Journal of Clinical Oncology. 27(21). 3423–3429. 187 indexed citations
16.
Chen, Weiqiu, Kai‐Feng Pan, Tao Ouyang, et al.. (2008). BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer. Breast Cancer Research and Treatment. 117(1). 55–60. 32 indexed citations
17.
Xu, Ye, Ailian Zhao, Tao Ouyang, et al.. (2008). Effect of p53 codon 72 genotype on breast cancer survival depends on p53 gene status. International Journal of Cancer. 122(12). 2761–2766. 12 indexed citations
18.
Li, Hongxia, Ye Xu, Tao Ouyang, et al.. (2006). The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women. Acta Oncologica. 45(5). 597–601. 16 indexed citations
19.
Li, Jinfeng, et al.. (2004). Preoperative chemotherapy of continuous infusion of 5-fluorouracil, epirubicin or pirarubicin and cyclophosphamine in operable primary breast cancer. Chinese Journal of Cancer Research. 16(3). 197–202. 1 indexed citations
20.
Gao, Wen, et al.. (2001). Bi-rads categorization and positive predictive value of mammographic features. Chinese Journal of Cancer Research. 13(3). 202–205. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tie Fan Breakdown of academic impact, for papers by Chiyomi Egawa Breakdown of academic impact, for papers by Zhaoqing Fan Breakdown of academic impact, for papers by Tatyana A. Grushko Breakdown of academic impact, for papers by Kirsi Syrjäkoski Breakdown of academic impact, for papers by Christine S. L. Lee Breakdown of academic impact, for papers by Anne‐Lise Børresen‐Dale Breakdown of academic impact, for papers by Farahnaz Forozan Breakdown of academic impact, for papers by Lauren Brusco Breakdown of academic impact, for papers by Hans Kristian Moen Vollan
Rankless by CCL
2026